Rare diseases
Investigational molecules
Locations
Back to Poland723 clinical trials in Bydgoszcz, Poland across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Baricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
PolandFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
PolandA study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandPhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
PolandEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PolandEfficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
PolandEfficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
PolandStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
PolandA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
PolandA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
PolandStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on respiratory syncytial virus (RSV) and pneumococcal infections in both adults and children. Studies include vaccine development for multiple age groups and assessment of immune responses.
Research emphasizes preventive measures and vaccine efficacy across different age groups.
Groundbreaking research into neurodegenerative conditions, with particular focus on early intervention strategies for Alzheimer's and Parkinson's disease treatment approaches.
Studies aim to slow disease progression and improve patient outcomes.
Comprehensive trials examining new treatments for various inflammatory disorders, including psoriasis, arthritis, and inflammatory bowel diseases.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
